Liven Pharma completes first export to Arab region

October 02, 2025 (MLN): Liven Pharma Limited (PSX: LIVEN) has completed its first-ever export to the Arab region, marking a significant milestone in the pharmaceutical company's international expansion strategy.

In a disclosure to shareholders, the company revealed that the export order, which was received during the last fiscal year, has now been completed.

The achievement represents a strategic breakthrough for Liven Pharma as it seeks to establish a presence in international markets.

"This achievement is the doorway for Liven Pharma Limited to increase its footprint and marks its presence in the international market, strengthening and unlocking new opportunities for the company," the company stated in its official communication.

The move into the Arab region comes as part of Liven Pharma's broader global expansion strategy, with management expressing confidence in the growth potential of international markets.

The company emphasized its commitment to delivering value to shareholders through strategic geographic diversification.

"We remain committed to grow and to make big profits for the sake of our valued shareholders, and always want to keep our shareholders informed and updated," the company said in its disclosure.

The successful completion of this first export order positions Liven Pharma to pursue additional opportunities in the Middle East and other international markets. 

Copyright Mettis Link News